Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epigenetic changes in solid and hematopoietic tumors.

Minoru Toyota1, Jean-Pierre J Issa

  • 1Sapporo Medical University, Sapporo, Japan.

Seminars in Oncology
|October 8, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone marrow immunosuppressive states associate with survival after guadecitabine and atezolizumab therapy in HMA-R/R MDS.

Blood neoplasia·2026
Same author

EZH2 and intracellular Ca<sup>2+</sup> signals interdependently coordinate alloreactive and CAR-T-cell responses.

Cellular & molecular immunology·2026
Same author

Modeling age-related methylation changes in vitro with intestinal organoids.

BMC biology·2026
Same author

DNA Methylation, Aging, and Cancer.

Epigenomes·2025
Same author

A phase 2 study of decitabine with or without carboplatin and arsenic trioxide in patients with MDS and AML.

Blood neoplasia·2025
Same author

ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in Cancer.

Cancer research·2025
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

Epigenetic mechanisms like DNA methylation and histone modifications are crucial for cellular memory and are hijacked in cancer to silence genes. Understanding these epigenetic changes aids in cancer risk assessment, early detection, and novel therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Cancer Biology

Background:

  • Epigenetic cellular memory involves DNA methylation, histone modifications, and RNA interference.
  • DNA methylation and histone modifications are implicated in neoplastic transformation.
  • Aberrant gene silencing via hypermethylation is a hallmark of cancer, affecting critical cancer-related pathways.

Purpose of the Study:

  • To explore the role of epigenetic mechanisms in cancer development and progression.
  • To investigate the clinical utility of epigenetic patterns in oncology.
  • To highlight the potential of epigenetic therapy in cancer treatment.

Main Methods:

  • Analysis of DNA methylation patterns in human cancers.
  • Profiling of epigenetic signatures across different tissues and tumors.

Related Experiment Videos

  • Examination of alterations in epigenetic machinery and effector genes in cancer.

    • Main Results:

    • Hypermethylation of CpG-rich promoters leads to stable gene silencing, utilized extensively in cancer.
    • Epigenetic signatures are tissue-specific and tumor-specific, with some cancers exhibiting epigenetic instability.
    • Aberrant promoter methylation accumulates in aging tissues, influenced by inflammation, diet, and genetics.

    Conclusions:

    • Epigenetic patterns are clinically valuable for cancer risk assessment, early detection, and prognosis.
    • Epigenetic alterations, including lesions in effector genes, contribute to cancer development.
    • Epigenetic therapy holds promise for transforming cancer treatment strategies.